tetradecanoylphorbol acetate and Angioedema

tetradecanoylphorbol acetate has been researched along with Angioedema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, F; Ballentine, SK; Bone, RF; Crysler, CS; Cummings, MD; DesJarlais, RL; Huang, H; Hufnagel, HR; Khalil, E; Marugán, JJ; Molloy, CJ; Ninan, N; Subasinghe, NL; Tomczuk, BE; Travins, JM	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Angioedema

Article	Year
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s. Bioorganic & medicinal chemistry letters, 2006, Apr-15, Volume: 16, Issue:8 Topics: Amidines; Angioedema; Arylsulfonates; Complement C1s; Fibrinolysin; Graft Rejection; Humans; Myocardial Ischemia; Serine Proteinase Inhibitors; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Thiophenes; Thrombin; Urokinase-Type Plasminogen Activator	2006

Article

Year

A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s.

Bioorganic & medicinal chemistry letters, 2006, Apr-15, Volume: 16, Issue:8

Topics: Amidines; Angioedema; Arylsulfonates; Complement C1s; Fibrinolysin; Graft Rejection; Humans; Myocardial Ischemia; Serine Proteinase Inhibitors; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Thiophenes; Thrombin; Urokinase-Type Plasminogen Activator

2006